Literature DB >> 22458690

Sequential proteolytic processing of an interferon-alpha receptor subunit by TNF-alpha converting enzyme and presenilins.

Peter D Pioli1, Abu M Z Saleh, Ashraf El Fiky, Kent L Nastiuk, John J Krolewski.   

Abstract

It is well established that interferons trigger tyrosine-kinase-dependent signaling via JAK kinases and STAT transcription factors. However, we have observed both IFNaR2 receptor cleavage and functional activity of the liberated intracellular domain (ICD), suggesting that interferon-alpha (IFN-alpha) can also signal via regulated intramembrane proteolysis (RIP), an evolutionarily conserved mechanism of receptor-mediated signaling. Sequential cleavage of the receptor ectodomain and transmembrane domain is a hallmark of the most common class of RIP. To investigate the mechanisms of IFNaR2 RIP signaling, we examined IFNaR2 cleavage by TNF-alpha converting enzyme (TACE) and presenilin proteases. We tracked the fate of epitope-tagged and fusion variants of IFNaR2 in cells expressing wild-type, mutant, or null versions of TACE and presenilins 1 and 2. Cleavage and subcellular location were determined by immunoblot, fluoresence microscopy, and reporter assays. We found that both TACE and presenilin 1/2 cleave IFNaR2, in a sequential manner that allows the ICD to move to the nucleus. TACE cleavage was induced by IFN-alpha but was not consistently required for the anti-proliferative effects of IFN-alpha. In conclusion, IFNaR2 is cleaved by TACE and Presenilin 1/2, suggesting that interferons signal by both kinase and RIP-mediated pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22458690      PMCID: PMC3390988          DOI: 10.1089/jir.2011.0116

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  54 in total

1.  Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons.

Authors:  P Marin; K L Nastiuk; N Daniel; J A Girault; A J Czernik; J Glowinski; A C Nairn; J Prémont
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

2.  Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.

Authors:  O Colamonici; H Yan; P Domanski; R Handa; D Smalley; J Mullersman; M Witte; K Krishnan; J Krolewski
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

3.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

Authors:  R A Black; C T Rauch; C J Kozlosky; J J Peschon; J L Slack; M F Wolfson; B J Castner; K L Stocking; P Reddy; S Srinivasan; N Nelson; N Boiani; K A Schooley; M Gerhart; R Davis; J N Fitzner; R S Johnson; R J Paxton; C J March; D P Cerretti
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

4.  Kinase-deficient forms of Jak1 and Tyk2 inhibit interferon alpha signaling in a dominant manner.

Authors:  K Krishnan; R Pine; J J Krolewski
Journal:  Eur J Biochem       Date:  1997-07-01

5.  Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction.

Authors:  H Yan; K Krishnan; J T Lim; L G Contillo; J J Krolewski
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

6.  The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals.

Authors:  S Gupta; H Yan; L H Wong; S Ralph; J Krolewski; C Schindler
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

7.  Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?

Authors:  María Paula Ceballos; Juan Pablo Parody; María de Luján Alvarez; Paola Inés Ingaramo; Cristina Ester Carnovale; María Cristina Carrillo
Journal:  Biochem Pharmacol       Date:  2011-08-06       Impact factor: 5.858

8.  Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation.

Authors:  M Vecchi; J Baulida; G Carpenter
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

9.  A mutant form of p135tyk2, an interferon-alpha inducible tyrosine kinase, suppresses the transformed phenotype of Daudi cells.

Authors:  E Davis; K Krishnan; H Yan; E W Newcomb; J J Krolewski
Journal:  Leukemia       Date:  1996-03       Impact factor: 11.528

10.  Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.

Authors:  H Yan; K Krishnan; A C Greenlund; S Gupta; J T Lim; R D Schreiber; C W Schindler; J J Krolewski
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

View more
  2 in total

1.  Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment.

Authors:  Pablo Aliaga-Gaspar; Isaac Hurtado-Guerrero; Nicolas Lundahl Ciano-Petersen; Patricia Urbaneja; Isabel Brichette-Mieg; Virginia Reyes; Jose Luis Rodriguez-Bada; Roberto Alvarez-Lafuente; Rafael Arroyo; Ester Quintana; Lluis Ramió-Torrentà; Ana Alonso; Laura Leyva; Oscar Fernández; Begoña Oliver-Martos
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

2.  IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19.

Authors:  Ingrid Fricke-Galindo; Alfonso Martínez-Morales; Leslie Chávez-Galán; Ranferi Ocaña-Guzmán; Ivette Buendía-Roldán; Gloria Pérez-Rubio; Rafael de Jesus Hernández-Zenteno; Abigail Verónica-Aguilar; Aimé Alarcón-Dionet; Hiram Aguilar-Duran; Ilse Adriana Gutiérrez-Pérez; Oscar Zaragoza-García; Jesús Alanis-Ponce; Angel Camarena; Brandon Bautista-Becerril; Karol J Nava-Quiroz; Mayra Mejía; Iris Paola Guzmán-Guzmán; Ramcés Falfán-Valencia
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.